HALEY NGUYEN: Open Payments
NPI 1194291484 · TUSTIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 27 payments from 13 companies in 2025. Trend: 2023 $3,398 · 2024 $562 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 5 | $298 |
| Insulet Corporation | 3 | $213 |
| Gilead Sciences, Inc. | 5 | $136 |
| Amgen Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $45 |
| ABBVIE INC. | 2 | $38 |
| Corcept Therapeutics | 2 | $30 |
| Lilly USA, LLC | 1 | $30 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: Dexcom G6 Transmitter, Omnipod, TEPEZZA, Wegovy, SYNTHROID, Korlym, JARDIANCE, ISTURISA.
Industry payments across CA — which companies pay providers there.
